MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level

    DI. Okhunova, G. Sattarovna, A. Babokhujaev (Tashkent, Uzbekistan)

    Objective: To increase the reliability of the development of dementia in patients with PD by a comparative assessment of clinical scales and neurosteroids Background: Parkinson's…
  • 2022 International Congress

    Real-World Treatment Patterns and Outcomes in Patients With Chorea Associated With Huntington Disease Using Tetrabenazine or Deutetrabenazine in Combination with Antipsychotic Drugs

    D. Claassen, H. Romdhani, R. Ayyagari, D. Goldschmidt, S. Zoye Moroz, A. Hernandez, S. Leo (Nashville, USA)

    Objective: To describe treatment patterns with vesicular monoamine transporter 2 inhibitors (VMAT2i; tetrabenazine [TBZ], or deutetrabenazine [DTBZ]) in combination with antipsychotic agents (APs) in patients…
  • 2022 International Congress

    X-Linked Dystonia Parkinsonism as the cause of Isolated Lingual Dystonia (ILD)

    D. Dakay, G. Saranza, Z. Leonardo, C. Klein, N. Brüggemann, A. Westenberger (Mandaue City, Philippines)

    Objective: This report aims to describe a 43-year-old Filipino male with ILD aggravated by speech and swallowing. This paper highlights the importance of including XDP…
  • 2022 International Congress

    Cross-cultural validation of the Cebuano version of a screening questionnaire for Parkinson’s Disease

    D. Dakay, F. Tangcalagan, E. Villanueva Iii, J. Abejero, G. Saranza (Mandaue City, Philippines)

    Objective: To determine the validity of the Cebuano version of a PD screening questionnaire Background: In the Philippines, actual prevalence of Parkinson’s Disease (PD) is…
  • 2022 International Congress

    Safety and Efficacy of unilaterally Focused Ultrasound Subthalamotomy in Early Parkinson´s Disease: The EARLY FOCUS I Study

    E. Natera-Villlaba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To assess the safety and efficacy of unilateral FUS subthalamotomy in early PD patients. Background: FUS subthalamotomy is feasible and therapeutically effective in Parkinson´s…
  • 2022 International Congress

    Long-term efficacy of unilateral high-intensity focused ultrasound subthalamotomy for Parkinson’s Disease

    R. Martínez-Fernández, E. Natera-Villalba, J. Máñez-Miró, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, L. Vela, F. Alonso-Frech, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To explore the long-term safety and efficacy of focused ultrasound subthalamotomy (FUS-STN). Background: Unilateral MRI-guided high-intensity FUS-STN improves motor signs of Parkinson’s disease (PD) [1]…
  • 2022 International Congress

    In Silico Study Reveals Cocaine Exposure Modulates Dopamine Neuron Firing Patterns by Inhibiting Small Conductance Calcium Activated Potassium Current

    CHI. Mahapatra (Mumbai, India)

    Objective: The neurological reason behind the loss of dopamine neurons causing Parkinson’s disease (PD) is an unsolved mystery. Background: As PD is identified as a…
  • 2022 International Congress

    May apomorphine be helpful for the axial symptoms of Parkinson’s Disease?

    A. Alonso-Canovas, P. Perez Torre, G. Sanchez Diez, A. Patiño Paton, N. Gonzalez, I. Parees Moreno, JC. Martinez Castrillo (Madrid, Spain)

    Objective: To assess the effect of continuous subcutaneous infusion of apomorphine on axial symptoms of Parkinson Disease. Background: Axial symptoms of Parkinson’s Disease may be…
  • 2022 International Congress

    Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.

    C. Listik, E. Listik, G. Santos, F. Vale, F. Rolim, D. Portela, N. Araújo, P. Carvalho, S. Camargos, J. Lapa, R. Otani, R. Costa, E. Barbosa, R. Cury, J. Limongi, F. Cardoso, H. Ferraz, D. Andrade (Sao Paulo, Brazil)

    Objective: To classify and better understand pain in Dystonia. Background: Pain is an incapacitating non-motor symptom in dystonia. Evidence indicates that pain’s descending modulatory systems…
  • 2022 International Congress

    Assessment of novel diffusion MRI metrics of cortical microstructure in the genetic continuum of Parkinson’s disease

    M. Torso, D. Tzaferou, M. Valotti, J. Hardwidge, I. Hardingham, Q. Guo, R. Comley, S. Chance, G. Ridgway (Oxford, United Kingdom)

    Objective: To investigate novel cortical diffusivity metrics in Parkinson’s disease (PD), including both prodromal and established genetic PD, alongside sporadic PD and healthy controls (HC).…
  • « Previous Page
  • 1
  • …
  • 507
  • 508
  • 509
  • 510
  • 511
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley